Page 76 - 22-0424
P. 76
The International Journal of the Royal Society of Thailand
Volume XI - 2019
Cheng Y, Wang F, Zhang P, Hu J. Risk prediction with electronic health records:
A deep learning approach. SDM. 2016;432–440. doi:10.1137/1.9781
611974348.49.
Chmielewski M, Lindholm B, Stenvinkel P, Ekstrom JT. The role of epigenetics in
kidney diseases. Prilozi. 2011;32:45–54.
Curtis LM and Agarwal A. Heme oxygenase-1 gene polymorphisms-toward
precision medicine for AKI. J Am Soc Nephrol. 2016;27:3229–3231.
doi:10.1681/ASN.2016060699.
D'Oto A, Tian Q-W, Davidoff AM, Yang J. Histone demethylases and their roles
in cancer epigenetics. J Med Oncol Ther. 2016;1:34–40.
Devarajan P. Genomic and proteomic characterization of acute kidney injury.
Nephron. 2015;131:85–91. doi:10.1159/000437237.
Doyle JF and Forni LG. Acute kidney injury: short-term and long-term effects.
Crit Care. 2016;20:188. doi:10.1186/s13054-016-1353-y.
Ebert MS and Sharp PA. Roles for microRNAs in conferring robustness to
biological processes. Cell. 2012;149:515–524. doi:10.1016/j.cell.2012.04.005.
Fieghen HE, Friedrich JO, Burns KE, Nisenbaum R, Adhikari NK, Hladunewich
MA, et al. The hemodynamic tolerability and feasibility of sustained low
efficiency dialysis in the management of critically ill patients with acute
kidney injury. BMC Nephrol. 2010;11:32–32. doi:10.1186/1471-2369-11-32.
Fontecha-Barriuso M, Martin-Sanchez D, Ruiz-Andres O, Poveda J, Sanchez-Niño
MD, Valiño-Rivas L, et al. Targeting epigenetic DNA and histone
modifications to treat kidney disease. Nephrol Dial Transplant.
2018;33:1875–1886. doi:10.1093/ndt/gfy009.
Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, et al.
Initiation strategies for renal-replacement therapy in the intensive care
unit. N Engl J Med. 2016;375:122–133. doi:10.1056/NEJMoa1603017.
Ginsburg GS and Phillips KA. Precision medicine: from science to value. Health
Aff (Millwood). 2018;37:694–701. doi: 10.1377/hlthaff.2017.1624.
Gunnerson KJ, Shaw AD, Chawla LS, Bihorac A, Al-Khafaji A, Kashani K, et al.
TIMP2*IGFBP7 biomarker panel accurately predicts acute kidney injury in
70 Precision Medicine in Acute kidney injury
11/7/2565 BE 13:28
_22-0424(055-076)7.indd 70 11/7/2565 BE 13:28
_22-0424(055-076)7.indd 70